Vizient Expands Children’s Hospital Supply Chain, Pharmacy Support
Event summary
- Vizient and Children’s Hospital Association (CHA) expanded their partnership to enhance supply chain, pharmacy, and analytics support for children’s hospitals.
- The agreement includes access to Vizient’s medical/surgical supplies catalog, cell/gene therapy expertise, pharmacy analytics, and capital spend insights.
- Vizient’s contract portfolio represents $156 billion in annual purchasing volume.
- CHA members will gain expanded consultant services in acute and non-acute care.
The big picture
The expanded partnership aligns with broader industry trends toward cost optimization and operational efficiency in healthcare. Vizient’s $156 billion annual purchasing volume underscores its scale in the sector, while the focus on pediatric care highlights the unique challenges faced by children’s hospitals. The deal reflects a strategic shift toward data-driven supply chain and pharmacy solutions in an increasingly complex healthcare landscape.
What we're watching
- Cost Control
- How Vizient’s expanded offerings will help children’s hospitals balance cost control amid increasing operational pressures.
- Therapeutic Innovation
- Whether the inclusion of cell and gene therapy expertise will position Vizient as a leader in high-cost therapeutic categories.
- Operational Efficiency
- The pace at which Vizient’s analytics and benchmarking tools drive measurable efficiency improvements for CHA members.